Foster 200/6

Therapeutic Indication:

Asthma: Foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate, patients not adequately controlled with inhaled corticosteroids and as-needed inhaled rapid-acting beta2-agonist, or for patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.

• Composition: Beclometasone Dipropionate Anhydrous 200 mcg/Actuation, Formoterol Fumarate Dihydrate 6 mcg/Actuation.
• Pharmaceutical Form: Pressurized Solution for inhalation.
• Method of Administration: Inhalation.
• How Supplied: Single Inhaler, 120 Actuations.
• Manufacturer: Chiesi Farmaceutici, Italy.